Antares Pharma (ATRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2011 | 12-2010 | 12-2009 | 12-2008 | 12-2007 | |
| Sales | 16,459 | 12,819 | 8,311 | 5,661 | 7,857 |
| Cost of Goods | 6,797 | 4,273 | 4,140 | 2,020 | 3,442 |
| Gross Profit | 9,661 | 8,546 | 4,171 | 3,641 | 4,415 |
| Operating Expenses | 14,895 | 14,845 | 14,005 | 15,859 | 13,503 |
| Operating Income | -4,437 | -6,027 | -9,694 | -12,198 | -8,646 |
| Interest Expense | 0 | 0 | 634 | 1,022 | 772 |
| Other Income | 49 | -65 | 36 | 529 | 839 |
| Pre-tax Income | -4,388 | -6,091 | -10,291 | -12,691 | -8,579 |
| Net Income Continuous | -4,388 | -6,091 | -10,291 | -12,691 | -8,579 |
| Net Income | $-4,388 | $-6,091 | $-10,291 | $-12,691 | $-8,579 |
| EPS Basic Total Ops | -0.05 | -0.07 | -0.14 | -0.19 | -0.14 |
| EPS Basic Continuous Ops | -0.05 | -0.07 | -0.14 | -0.19 | -0.14 |
| EPS Diluted Total Ops | -0.05 | -0.07 | -0.14 | -0.19 | -0.14 |
| EPS Diluted Continuous Ops | -0.05 | -0.07 | -0.14 | -0.19 | -0.14 |
| EBITDA(a) | $-4,259 | $-5,838 | $-9,261 | $-11,645 | $-5,868 |